CCND2 and acute myeloid leukemia: AML containing t(8;21) are associated with stabilizing mutations of CCND2 and inactivating mutations of MGA (44,46–47) which promote the G1 to S phase transition, but palbociclib had little effect, even in combination with PHA767491 (negative data not shown).